Evaluation of dapsone and its synthetic derivative DDS‑13 in cancer <i>in vitro</i>.

Authors:
Cabral-Pacheco GA; Flores-Morales V; Garza-Veloz I; Damián-Sandoval M; Martínez-Flores RB and 4 more

Journal:
Exp Ther Med

Publication Year: 2023

DOI:
10.3892/etm.2023.12335

PMCID:
PMC10739155

PMID:
38144918

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Exp Ther Med

Abbreviation: Exp Ther Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine, Research & Experimental

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A novel animal model of abdominal aortic aneurysm by mechanical injury.
Kim SH; Park JH; Kim DH and 3 more (2024) - Transparency Score: 3/6
Antibiotic administration aggravates asthma by disrupting gut microbiota and the intestinal mucosal…
Xu CL; Wang C; Li GB and 3 more (2024) - Transparency Score: 4/6
Anti‑osteoclastogenic effect of fermented mealworm extract by inhibiting RANKL‑induced NFATc1 actio…
Ham JR; Lee MK. (2024) - Transparency Score: 3/6
Biochanin A inhibits endothelial dysfunction induced by IL‑6‑stimulated endothelial microparticles …
Liu J; Lin C; Li B and 8 more (2024) - Transparency Score: 3/6
CHL1 inhibits cell proliferation, migration and invasion by regulating the NF‑κB signaling pathway …
Bao M; Li S; Zhu Y and 3 more (2024) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"Funding: The present study was funded by the Academic Unit of Human Medicine and Health Sciences of the Autonomous University of Zacatecas and by CONACYT via a scholarship fund (grant no. 2021-000018-02NACF-15274)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025